- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
The post Marlaina Goedel Marks Two Years Insulin-Free After Becoming the First Patient in Eledon’s Groundbreaking Islet Cell Transplant Trial appeared first on Eledon Pharmaceuticals, Inc..
The post Inside Eledon’s Push to Transform Type 1 Diabetes Care appeared first on Eledon Pharmaceuticals, Inc..
The post Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study appeared first on Eledon Pharmaceuticals, Inc..
The post This Biotech CEO Is Creating A Cure For Type 1 Diabetes -Meet The CEO Of Eledon Pharma – $ELDN appeared first on Eledon Pharmaceuticals, Inc..
The post Rethinking rejection in kidney transplant appeared first on Eledon Pharmaceuticals, Inc..
The post Efforts Address Immune Suppression in Islet Cell Transplants appeared first on Eledon Pharmaceuticals, Inc..
The post Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence appeared first on Eledon Pharmaceuticals, Inc..
The post Tegoprubart Sustains Increased eGFR Longterm Compared to Tacrolimus appeared first on Eledon Pharmaceuticals, Inc..
The post All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study appeared first on Eledon Pharmaceuticals, Inc..
The post Diabetes Dialogue: Tegoprubart and Freedom from Insulin in Type 1 Diabetes appeared first on Eledon Pharmaceuticals, Inc..